SERPINB3 and non-small cell lung carcinoma: As an example, in early-stage non-small cell lung cancer (NSCLC), the utility of neuron-specific enolase (NSE), CA125, and squamous cell carcinoma antigen (SCC) was found to be limited, even when these three markers were used in combination (12).